{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:55Z","timestamp":1792424455347,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14059-y","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:15:47Z","timestamp":1784718947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospital length of stay and cost associated with routine-care documentation of probable or suspected fungal infection among patients hospitalized with acute myeloid leukemia: a propensity score analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Chengming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"12","key":"14059_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei A, Appelbaum F, Craddock C, DiNardo C, Dombret H. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"issue":"9550","key":"14059_CR2","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","volume":"368","author":"E Estey","year":"2006","unstructured":"Estey E, D\u00f6hner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(06)69780-8.","journal-title":"Lancet"},{"issue":"4","key":"14059_CR3","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"A Freifeld","year":"2011","unstructured":"Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56\u201393. https:\/\/doi.org\/10.1093\/cid\/cir073.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"14059_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.6004\/jnccn.2024.0056","volume":"22","author":"L Baden","year":"2024","unstructured":"Baden L, Swaminathan S, Almyroudis N, Angarone M, Baluch A, Barros N. Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(9):617\u201344. https:\/\/doi.org\/10.6004\/jnccn.2024.0056.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"14059_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi M, Martinelli G. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353(10):977\u201387. https:\/\/doi.org\/10.1056\/NEJMoa044097.","journal-title":"N Engl J Med"},{"issue":"8","key":"14059_CR6","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068\u201375.","journal-title":"Haematologica"},{"issue":"4","key":"14059_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95(4):644\u201350. https:\/\/doi.org\/10.3324\/haematol.2009.012054.","journal-title":"Haematologica"},{"issue":"2","key":"14059_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1128\/AAC.01525-13","volume":"58","author":"M Gomes","year":"2014","unstructured":"Gomes M, Mulanovich V, Jiang Y, Lewis R, Kontoyiannis D. Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrob Agents Chemother. 2014;58(2):865\u201373. https:\/\/doi.org\/10.1128\/AAC.01525-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"23","key":"14059_CR9","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","volume":"3","author":"I Aldoss","year":"2019","unstructured":"Aldoss I, Dadwal S, Zhang J, Tegtmeier B, Mei M, Arslan S. Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents. Blood Adv. 2019;3(23):4043\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2019000930.","journal-title":"Blood Adv"},{"issue":"6","key":"14059_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/jof8060583","volume":"8","author":"C Cattaneo","year":"2022","unstructured":"Cattaneo C, Candoni A, Gramegna D. High incidence of invasive fungal diseases in patients with FLT3-mutated AML treated with midostaurin: results of a multicenter observational SEIFEM study. J Fungi (Basel). 2022;8(6):583. https:\/\/doi.org\/10.3390\/jof8060583.","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"14059_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"J Donnelly","year":"2020","unstructured":"Donnelly J, Chen S, Kauffman C, Steinbach W, Baddley J, Verweij P. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"14059_CR12","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"PB De","year":"2008","unstructured":"De PB, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T. Revised definitions of invasive fungal disease from the EORTC\/MSG Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321. https:\/\/doi.org\/10.1086\/588660.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"14059_CR13","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","volume":"72","author":"T Mercier","year":"2021","unstructured":"Mercier T, Castagnola E, Marr K, Wheat L, Verweij P, Maertens J. Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases. Clin Infect Dis. 2021;72(Suppl 2):S89\u201394. https:\/\/doi.org\/10.1093\/cid\/ciaa1786.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"14059_CR14","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg B, Ruhnke M, Shoham S, Vazquez J. EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis. 2021;72(Suppl 2):S121\u20137. https:\/\/doi.org\/10.1093\/cid\/ciaa1751.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"14059_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/524324","volume":"29","author":"D Chang","year":"2008","unstructured":"Chang D, Burwell L, Lyon G, Pappas P, Chiller T, Wannemuehler K. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol. 2008;29(1):25\u201330. https:\/\/doi.org\/10.1086\/524324.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"14059_CR16","doi-asserted-by":"publisher","first-page":"e0238889","DOI":"10.1371\/journal.pone.0238889","volume":"15","author":"J Valentine","year":"2020","unstructured":"Valentine J, Worth L, Verspoor K, Hall L, Yeoh D, Thursky K. Classification performance of administrative coding data for detection of invasive fungal infection in paediatric cancer patients. PLoS ONE. 2020;15(9):e0238889. https:\/\/doi.org\/10.1371\/journal.pone.0238889.","journal-title":"PLoS ONE"},{"issue":"4","key":"14059_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1086\/502684","volume":"27","author":"E Sherman","year":"2006","unstructured":"Sherman E, Heydon K, St John K, Teszner E, Rettig S, Alexander S. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol. 2006;27(4):332\u20137. https:\/\/doi.org\/10.1086\/502684.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"14059_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jinf.2018.02.012","volume":"76","author":"PR van de Visser","year":"2018","unstructured":"van de Visser PR, de Dekkers L. The burden of invasive aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review. J Infect. 2018;76(6):550\u201362. https:\/\/doi.org\/10.1016\/j.jinf.2018.02.012.","journal-title":"J Infect"},{"issue":"5","key":"14059_CR19","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1128\/AAC.01462-10","volume":"55","author":"M Ananda-Rajah","year":"2011","unstructured":"Ananda-Rajah M, Cheng A, Morrissey C, Spelman T, Dooley M, Neville A. Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach. Antimicrob Agents Chemother. 2011;55(5):1953\u201360. https:\/\/doi.org\/10.1128\/AAC.01462-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"14059_CR20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/cid\/ciy776","volume":"68","author":"K Benedict","year":"2019","unstructured":"Benedict K, Jackson B, Chiller T, Beer K. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68(11):1791\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy776.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"14059_CR21","doi-asserted-by":"publisher","first-page":"myaf049","DOI":"10.1093\/mmy\/myaf049","volume":"63","author":"K Benedict","year":"2025","unstructured":"Benedict K, Gold J, Chiller T, Lyman M. Economic burden of fungal diseases in the United States. Med Mycol. 2025;63(6):myaf049. https:\/\/doi.org\/10.1093\/mmy\/myaf049.","journal-title":"Med Mycol"},{"issue":"1","key":"14059_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"P Rosenbaum","year":"1983","unstructured":"Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355. https:\/\/doi.org\/10.1093\/biomet\/70.1.41.","journal-title":"Biometrika"},{"issue":"3","key":"14059_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"P Austin","year":"2011","unstructured":"Austin P. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivar Behav Res"},{"issue":"25","key":"14059_CR24","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"P Austin","year":"2009","unstructured":"Austin P. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107. https:\/\/doi.org\/10.1002\/sim.3697.","journal-title":"Stat Med"},{"issue":"1","key":"14059_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"E Stuart","year":"2010","unstructured":"Stuart E. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1):1\u201321. https:\/\/doi.org\/10.1214\/09-STS313.","journal-title":"Stat Sci"},{"issue":"6","key":"14059_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"S Cole","year":"2008","unstructured":"Cole S, Hern\u00e1n M. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656\u201364. https:\/\/doi.org\/10.1093\/aje\/kwn164.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"14059_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"EE von Altman","year":"2007","unstructured":"von Altman EE, Egger D, Pocock M, G\u00f8tzsche S, Vandenbroucke P. The Strengthening the Reporting of Observational Studies in Epidemiology statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010.","journal-title":"Ann Intern Med"},{"issue":"10","key":"14059_CR28","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"J Vandenbroucke","year":"2007","unstructured":"Vandenbroucke J, von Altman EE, G\u00f8tzsche D, Mulrow P, Pocock C. Strengthening the Reporting of Observational Studies in Epidemiology: explanation and elaboration. PLoS Med. 2007;4(10):e297. https:\/\/doi.org\/10.1371\/journal.pmed.0040297.","journal-title":"PLoS Med"},{"key":"14059_CR29","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Vienna (Austria): R Foundation for Statistical Computing; 2026 [cited 2026 Jul 17]. Available from: https:\/\/www.R-project.org\/."},{"issue":"8","key":"14059_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho D, Imai K, King G, Stuart E. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1\u201328. https:\/\/doi.org\/10.18637\/jss.v042.i08.","journal-title":"J Stat Softw"},{"key":"14059_CR31","unstructured":"Greifer Ncobalt. Covariate balance tables and plots. R package version 462 [Internet]. 2025. Available from: https:\/\/ngreifer.github.io\/cobalt\/."},{"issue":"43","key":"14059_CR32","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686. https:\/\/doi.org\/10.21105\/joss.01686.","journal-title":"J Open Source Softw"},{"key":"14059_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2nd ed. Cham: Springer; 2016. https:\/\/doi.org\/10.1007\/978-3-319-24277-4.","edition":"2"},{"issue":"4","key":"14059_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2307\/1912934","volume":"48","author":"H White","year":"1980","unstructured":"White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48(4):817\u201338. https:\/\/doi.org\/10.2307\/1912934.","journal-title":"Econometrica"},{"issue":"1","key":"14059_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/aos\/1176344552","volume":"7","author":"B Efron","year":"1979","unstructured":"Efron B. Bootstrap methods: another look at the jackknife. Ann Stat. 1979;7(1):1\u201326. https:\/\/doi.org\/10.1214\/aos\/1176344552.","journal-title":"Ann Stat"},{"issue":"12","key":"14059_CR36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1093\/jac\/dky286","volume":"73","author":"J Maertens","year":"2018","unstructured":"Maertens J, Girmenia C, Br\u00fcggemann R, Duarte R, Kibbler C, Ljungman P. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother. 2018;73(12):3221\u201330. https:\/\/doi.org\/10.1093\/jac\/dky286.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"14059_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll A, Skiada A. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102(3):433\u201344. https:\/\/doi.org\/10.3324\/haematol.2016.152900.","journal-title":"Haematologica"},{"issue":"6","key":"14059_CR38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bmt.2011.178","volume":"47","author":"O Marchetti","year":"2012","unstructured":"Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transpl. 2012;47(6):846\u201354. https:\/\/doi.org\/10.1038\/bmt.2011.178.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"14059_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"T Patterson","year":"2016","unstructured":"Patterson T, Thompson G 3rd, Denning D, Fishman J, Hadley S, Herbrecht R. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360. https:\/\/doi.org\/10.1093\/cid\/ciw326.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"14059_CR40","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"P Pappas","year":"2016","unstructured":"Pappas P, Kauffman C, Andes D, Clancy C, Marr K, Ostrosky-Zeichner L. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1\u201350. https:\/\/doi.org\/10.1093\/cid\/civ933.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"14059_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3324\/haematol.2012.065110","volume":"98","author":"A Skiada","year":"2013","unstructured":"Skiada A, Lanternier F, Groll A, Pagano L, Zimmerli S, Herbrecht R. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from ECIL 3. Haematologica. 2013;98(4):492\u2013504. https:\/\/doi.org\/10.3324\/haematol.2012.065110.","journal-title":"Haematologica"},{"issue":"1","key":"14059_CR42","doi-asserted-by":"publisher","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","volume":"4","author":"S Vallabhaneni","year":"2017","unstructured":"Vallabhaneni S, Benedict K, Derado G, Mody R. Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000\u20132013. Open Forum Infect Dis. 2017;4(1):ofw268. https:\/\/doi.org\/10.1093\/ofid\/ofw268.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"14059_CR43","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","volume":"54","author":"A Kim","year":"2011","unstructured":"Kim A, Nicolau D, Kuti J. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses. 2011;54(5):e301\u201312. https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01903.x.","journal-title":"Mycoses"},{"key":"14059_CR44","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12879-016-2023-z","volume":"16","author":"D Kontoyiannis","year":"2016","unstructured":"Kontoyiannis D, Yang H, Song J, Kelkar S, Yang X, Azie N. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis. 2016;16:730. https:\/\/doi.org\/10.1186\/s12879-016-2023-z.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"14059_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"O Cornely","year":"2007","unstructured":"Cornely O, Maertens J, Winston D, Perfect J, Ullmann A, Walsh T. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348\u201359. https:\/\/doi.org\/10.1056\/NEJMoa061094.","journal-title":"N Engl J Med"},{"issue":"4","key":"14059_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"A Ullmann","year":"2007","unstructured":"Ullmann A, Lipton J, Vesole D, Chandrasekar P, Langston A, Tarantolo S. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356(4):335\u201347. https:\/\/doi.org\/10.1056\/NEJMoa061098.","journal-title":"N Engl J Med"},{"issue":"6","key":"14059_CR47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning D, Patterson T, Bennett J, Greene R, Oestmann J. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408\u201315. https:\/\/doi.org\/10.1056\/NEJMoa020191.","journal-title":"N Engl J Med"},{"key":"14059_CR48","doi-asserted-by":"publisher","unstructured":"Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387(10020):760-769. https:\/\/doi.org\/10.1016\/S0140-6736(15)01159-9.","DOI":"10.1016\/S0140-6736(15)01159-9"},{"issue":"Suppl 6","key":"14059_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1469-0691.12428","volume":"20","author":"C Cordonnier","year":"2014","unstructured":"Cordonnier C, Robin C, Alanio A, Bretagne S. Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing. Clin Microbiol Infect. 2014;20(Suppl 6):27\u201335. https:\/\/doi.org\/10.1111\/1469-0691.12428.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"14059_CR50","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","volume":"118","author":"D Kontoyiannis","year":"2011","unstructured":"Kontoyiannis D, Lewis R. How I treat mucormycosis. Blood. 2011;118(5):1216\u201324. https:\/\/doi.org\/10.1182\/blood-2011-03-316430.","journal-title":"Blood"},{"key":"14059_CR51","doi-asserted-by":"publisher","unstructured":"Bang H, Robins J. Doubly robust estimation in missing data and causal inference models. 2005. https:\/\/doi.org\/10.1111\/j.1541-0420.2005.00377.x.","DOI":"10.1111\/j.1541-0420.2005.00377.x"},{"key":"14059_CR52","volume-title":"Causal Inference: What If","author":"M Hern\u00e1n","year":"2020","unstructured":"Hern\u00e1n M, Robins J. Causal Inference: What If. Boca Raton: Chapman & Hall\/CRC; 2020."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14059-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:02:23Z","timestamp":1792422143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14059"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14059-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ganzhou People\u2019s Hospital Ethics Committee (approval no. PJB2026-135-01) and was conducted in accordance with the Declaration of Helsinki. The ethics committee waived the requirement for informed consent because the study used retrospective routinely collected data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1824"}}